Nurse Practitioner, Community Health · New York, NY
NPI
1053715243
Since 2014
Specialty
Nurse Practitioner, Community Health
Code 363LC1500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3418 Broadway, 2nd Floor
New York, NY, 10031
Phone (212) 283-2099
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,208
50 services
Medicare patients, 2024
29
Average age 75
Drug cost, 2024
$5.4M
9,327 prescriptions
Company payments, 2025
$17K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edwin A Torres was code 99214 (office e&m - established), 22 times for 16 patients. In total Edwin A Torres billed 50 services in 9 codes, and Medicare paid $4,208.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 22 | 16 | $86.14 | $1,895 |
| 99215 Office E&M - Established | Office | 15 | 14 | $128.75 | $1,931 |
By year: 2022 $5,661 for 77 services; 2023 $4,530 for 58 services; 2024 $4,208 for 50 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edwin A Torres prescribed most often to Medicare patients was Ozempic (Semaglutide), with 901 prescriptions and refills. In total Edwin A Torres wrote 9,327 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 901 | 1,467 | 182 | $1.4M |
| Pioglitazone Hcl Generic | 781 | 1,955 | 222 | $6,993 |
| Atorvastatin Calcium Generic | 767 | 2,101 | 289 | $12K |
| Trulicity Dulaglutide | 570 | 785 | 116 | $729K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 563 | 1,113 | 144 | $609K |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 538 | 874 | 113 | $458K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 497 | 583 | 99 | $394 |
| Mounjaro Tirzepatide | 463 | 748 | 114 | $767K |
| Tresiba Flextouch U-200 Insulin Degludec | 434 | 951 | 119 | $271K |
| Ezetimibe Generic | 410 | 1,082 | 135 | $12K |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 399 | 803 | 129 | $5,107 |
| Rosuvastatin Calcium Generic | 261 | 663 | 96 | $3,785 |
| Rybelsus Semaglutide | 174 | 295 | 44 | $266K |
| Metformin Hcl Generic | 171 | 442 | 59 | $1,386 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 156 | 345 | 66 | $11K |
Brand drugs: 4,712 claims; generic drugs: 3,281 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edwin A Torres $17K ($17K in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $9,096.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 24 | $9,096 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $5,368 |
| Corcept Therapeutics CORT | 9 | $1,208 |
| Lilly USA, LLC LLY | 2 | $704 |
| Xeris Pharmaceuticals, Inc. | 6 | $235 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $112 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $44.62 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.33 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.54 |
| Insulet Corporation PODD | 1 | $21.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.